Anixa Biosciences announced that Dr. Robert Wenham will present data from their Phase 1 clinical trial of a novel CAR-T therapy targeting ovarian cancer at the ESMO Congress in December 2026. The trial, conducted at Moffitt Cancer Center, is testing liraltagene autoleucel (lira-cel) for safety and preliminary efficacy in recurrent ovarian cancer, with no dose-limiting toxicities observed so far. The study has advanced to the fifth cohort with a 100-fold dose increase from the initial patient and plans to escalate further to a 1,000-fold increase. Early clinical observations include stable disease in one patient after 90 days and multiple patients surviving beyond one year, highlighting the therapy's potential. The presentation will share progress with the international oncology community as Anixa continues development in collaboration with Moffitt.
Anixa Biosciences' ovarian cancer CAR-T clinical trial presentation is noted here with Pluang's health sector data as of Nov 04, 2026 19:41 WIB: Among 150 priced US health stocks, 121 rose and 23 fell. Notable movers include Oscar Health Inc (OSCR) at USD 35.20 with an 8.61% increase and 84% buy order activity, Bruker Corporation (BRKR) at USD 60.45 up 6.99%, and Amgen, Inc. (AMGN) at USD 489.98 with a 6.23% rise and 68% buy order activity.
Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...
etoro has agreed to acquire LB Finanzas, a leading Argentine all-in-one financial app, to strengthen its presence in Latin America's fast-growing fintech market. LB Finanzas offers integrated investing and payment solutions, catering to Argentine ret...
JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...
KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...
Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc as of November 3, 2026. This disclosure is part of regulatory requirements under the Takeover Code for investors holding 1% or more in relevan...
